Ads
related to: docetaxel and carboplatin breast cancer risk assessment testmyriad.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
TCH is a chemotherapy regimen consisting of Taxotere (docetaxel), carboplatin and Herceptin (trastuzumab), which is used to treat breast cancer. References
Docetaxel (DTX or DXL), sold under the brand name Taxotere among others, is a chemotherapy medication used to treat a number of types of cancer. [6] This includes breast cancer, head and neck cancer, stomach cancer, prostate cancer and non-small-cell lung cancer. [7] It may be used by itself or along with other chemotherapy medication. [6]
She uses a free interactive tool with all her patients to determine their risk level: the Tyrer-Cuzick Risk Assessment Calculator for breast cancer. The tool looks at personal, familial, and ...
Using the BCRAT test, a five-year risk of more than 1.66% is considered high. But there are some important caveats and considerations for what those scores mean, as well as other important factors ...
The Black Women’s Health Study Breast Cancer Risk Calculator launched in 2021 and estimates short-term risk for women between the ages of 30 and 70. It gave me a 10-year risk of 0.8%, compared ...
Oncologists are already individualizing dosing of some cancer drugs based on exposure. Carboplatin [29]: 4 and busulfan [30] [31] dosing rely upon results from blood tests to calculate the optimal dose for each person. Simple blood tests are also available for dose optimization of methotrexate, [32] 5-FU, paclitaxel, and docetaxel. [33] [34]
Ad
related to: docetaxel and carboplatin breast cancer risk assessment test